VivioMD review
Graded on whether a price is published, checkable, and still true at month two — how we grade · how we verify prices
VivioMD charges $199 a month for compounded GLP-1 on the page its own buttons lead to. Five other live pages on the same site price the same product between $149 and $279.
Neither figure is stable. Five other live pages on this same site price these two products differently — all returning a normal page, all listed in the company's own sitemap, none dated or marked superseded.
- Advertised $199, actually $289
- Month-to-month price published
- States not published
- FDA warning letters: 0 of 1 matched
- Prices read September 2026
Read first-hand, not from a feed.
Distinct plans priced.
Added by the time you're billed.
This link pays us nothing. It's here because the price is checkable.
The verdict
Six prices for one product across six indexable pages, none marked stale and none reconciled. Underneath them, a published contract with a note to the copywriter where the arbitration, liability and governing-law sections should be.
This link pays us nothing. It's here because the price is checkable.
Quick facts
Key facts
- Compounded GLP-1 injection
- $199 a month on the funnel page
- The same product elsewhere on the site
- Priced five other ways across five live pages
- Dual-agonist injection
- $289 here, and higher on four other live pages
- Dissolving tablets
- $239 a month
- Brand Ozempic
- $1,299 a month
- Governing law
- None — the section is missing from the published terms
- Who prescribes
- OpenLoop Healthcare Partners P.C.
- Pharmacy
- Not named across twenty-one pages
- States
- Fifty on the homepage, forty-nine in the terms
- Dose surcharge
- None — the homepage promises flat pricing
Pros and cons
What we like
- The prescribing group, OpenLoop Healthcare Partners P.C., is named in the footer of every page.
- The compounding disclaimer is complete and accurate, and names the brand manufacturers properly.
- Full safety information is published for every drug it sells, brand and compounded.
- The homepage promises flat pricing that does not rise with your dose.
- A live provider consult is included with every plan.
- The refund policy is specific about timing and about disqualification.
What could be better
- Six different prices for the same product across six live, indexable pages.
- The published terms contain an editor's note instead of the arbitration, liability and governing-law sections.
- There is therefore no governing law named anywhere.
- The homepage says fifty states and the terms say forty-nine, excluding Louisiana.
- No pharmacy is named across twenty-one pages.
- Six outcome statistics are presented with no source.
- Products are named by euphemism, and the one molecule named is attached to a product it cannot be.
- Eleven duplicate advertising landing pages and an /old-home are exposed to crawlers in the sitemap.
What it is
VivioMD sells compounded GLP-1 injections, a dual-agonist injection, dissolving tablets and brand Ozempic at cash price. The prescribing is done by OpenLoop Healthcare Partners P.C. and its affiliated professional entities, named in the footer of every page — the usual separation between the brand you buy from and the clinicians who prescribe.
The company is VivioMD Group LLC, at a Lewes, Delaware address of the kind registered-agent services use. Its compounding disclaimer is complete and accurate, and it publishes full safety information for every drug it sells. Those are real points in its favor and they are why this is a failing grade rather than an unreadable site.
Its products are named by euphemism rather than by molecule. On the page the prices come from, they are "Personalized Care" items; the only page that names a molecule attaches the same one to two different products, including one it cannot be.
Every price we found
| Plan | Advertised | What you actually pay | The gap | Read on |
|---|---|---|---|---|
| Personalized Care: GLP-1 injectionBilled monthly on the page every homepage button leads to. Five other live pages price the same product differently. | not published | $199 | not comparable | September 2026 |
| Personalized Care: GLP-1 and GIP injectionBilled monthly. Four other live pages price it higher. | not published | $289 | not comparable | September 2026 |
| Personalized Care: GLP-1 tabletsOne dissolvable tablet per day, billed monthly. | not published | $239 | not comparable | September 2026 |
| Ozempic, brandBilled monthly. The card notes that availability is subject to change. | not published | $1,299 | not comparable | September 2026 |
This link pays us nothing. It's here because the price is checkable.
What it actually costs
The price depends on which advertisement you clicked. The same compounded GLP-1 injection is $199, $249, $179, $149 and $279 on five different live pages of this one site.
We publish the $199 set because it is where every button on the homepage actually sends you, and because it is the lowest — so it is the number the company's own funnel puts in front of a buyer. But all six sets were read on the same day, all six pages return 200, and all six are listed in the company's own sitemap, which means search engines are being shown them too. None carries a date, a note, or anything marking it superseded. This is not the usual gap between an advertised price and the real one — it is six different advertised prices with no real one named.
The dual-agonist injection is $289 on the funnel page and $339 on four others. The tablets are $239, or $279, or $249. Ozempic is $1,299. A shopper cannot be wrong about the price here, because there is no single price to be right about.
The published Terms of Use print a bracketed instruction to a copywriter where the substantive sections belong — so there is no governing law, no arbitration clause and no limitation of liability in the document.
The same page's preamble tells you that all disputes will be resolved by binding arbitration and directs you to a section that does not exist in the document. Indemnification, limitation of liability and governing law are in the same position: named in a list of things to keep, and then not there. Whatever you are agreeing to when you buy, it is not what that page says you are agreeing to.
The homepage also claims licensed providers in all fifty states while the terms say forty-nine, excluding Louisiana. Six outcome statistics — including a total pounds lost and a claim that ninety percent maintain most of their loss after a year and a half — carry no source of any kind.
Who it's wrong for
- Anyone who wants to know the price. There are six, all live, all indexable, none reconciled.
- Anyone who wants an enforceable contract. The arbitration, liability and governing-law sections were never written into the published terms.
- Anyone in Louisiana, who is told yes by the homepage and no by the terms.
- Anyone who wants to know what they are injecting. The products are named by euphemism, and the one page that names a molecule attaches it to a product it cannot be.
- Anyone who wants to know which pharmacy dispenses. Across twenty-one pages, not one is named.
Medications available
- Personalized Care: GLP-1 injectionCompounded$199 a month
The molecule is not named on this page.
- Personalized Care: GLP-1 and GIP injectionCompounded$289 a month
- Personalized Care: GLP-1 tabletsCompounded$239 a month
One dissolvable tablet per day.
- OzempicBrand$1,299 a month
Availability subject to change.
Is VivioMD legit?
VivioMD is operated by VivioMD Group LLC, 16192 Coastal Highway, Lewes, DE 19958. We read that off the company’s own terms of use on September 2026.
What that means
A known-positive control passed in the same run, so a real match would have surfaced. A letter would be worth knowing about; it would not by itself disqualify a seller.Pharmacy, prescribers and safety checks
- Legal entityVivioMD Group LLC, at a Delaware registered-agent address
- Who prescribesOpenLoop Healthcare Partners P.C. and affiliated entities
- Pharmacy namedNot disclosed
- Drug formCompounded, with a complete and accurate FDA disclaimer
- Governing lawAbsent — the section is missing from the published terms
- ArbitrationPromised in the preamble; the clause does not exist
- Canceling72 hours before the next billing date
- RefundsFull within 72 hours if no service received; full if disqualified
- States servedFifty claimed on the homepage, forty-nine in the terms
Common questions
How much does VivioMD cost per month?
It depends which page you land on. On the signup page every homepage button leads to, the compounded GLP-1 injection is $199 a month, the dual-agonist is $289, tablets are $239 and brand Ozempic is $1,299. Five other live pages on the same site carry different price sets for those same products.
Why does VivioMD show different prices on different pages?
The site runs eleven advertising landing pages, and they carry different price sets from the main funnel. All of them return a normal page, all are listed in the company's own sitemap, and none is dated or marked superseded — so which price you meet depends on which advertisement brought you in.
What law governs a VivioMD purchase?
None is named. The published Terms of Use print a bracketed instruction to a copywriter in place of the substantive sections, so Governing Law, Dispute Resolution, Arbitration, Indemnification and Limitation of Liability are listed as things to keep and then are not in the document — while the preamble still tells you disputes will go to binding arbitration.
Does VivioMD serve Louisiana?
Its homepage says it has licensed providers in all fifty states. Its terms say it offers services in forty-nine and not in Louisiana. The terms are the more specific statement and we would treat them as controlling.
Which pharmacy does VivioMD use?
It does not name one. Across twenty-one pages read in full, four separate passages describe independent state-licensed compounding pharmacies without identifying any of them.
Does the VivioMD price rise as my dose increases?
The homepage says no — "Flat pricing — never goes up as your dose increases." That promise is made on the homepage and is not restated in the terms or the refund policy, and given the state of the terms document there is nothing in the contract to hold them to it.
Why we gave VivioMD a F
Read the full grading rationale
The price of a VivioMD prescription depends on which advertisement you clicked. On /signup, where every button on the homepage sends you, compounded GLP-1 is $199 a month. On /landing it is $249. On /landing3 it is $179, on /landing4 $149, on /landing-new $179, on /landing-tab $279 — six live, indexable pages, all in the company's own sitemap, all read on the same day, pricing the same product six ways. No page reconciles them and none is marked stale. That alone is the finding this site exists to surface, and it is why the grade is what it is. The contract is worse. The published Terms of Use print, in visible body text where the substantive sections belong, a bracketed instruction to a copywriter listing the sections to keep — so Dispute Resolution, Arbitration, Limitation of Liability, Indemnification and Governing Law do not exist in the document, while the same page's preamble tells the reader that all disputes "will be resolved by binding arbitration" and points at a section that is not there. There is no governing law. The homepage claims providers in all 50 states and the terms say 49, excluding Louisiana. No pharmacy is named across 21 pages. Six outcome statistics, including "Over 231,650 lbs lost" and "90% maintain most of their weight loss", are presented with no source. What it does do well: OpenLoop Healthcare Partners P.C. is named as the prescriber, and the compounding disclaimer in the footer is accurate and complete.
What that means
Screening is by entity — the company’s own domain plus the address it publishes — never by brand name, because a brand name matches every namesake. Where a company publishes no address, the address half of that match is never exercised, and the result is recorded as the weaker kind of absence rather than a clean record. A known-positive control passed in the same run, so a real match would have surfaced. A letter would be worth knowing about; it would not by itself disqualify a seller.How we reviewed VivioMD
- We read twenty-one pages in full on the same day, including every advertising landing page in the company's sitemap, which is how the six competing price sets surfaced. We recorded each set separately and did not average or merge them.
- We publish the signup set because every call to action on the homepage resolves to it and it is the lowest, so it is the figure the company's own funnel puts in front of a buyer — not because it is more authoritative than the others.
- The placeholder in the Terms of Use was read from the rendered visible body text, not from the markup, so it is text a patient actually sees.
- We walked the assessment twelve screens deep with dummy data. It ended at a disqualification screen and three further attempts crashed on custom dropdowns, so no plan screen was reached and every price we publish comes from a marketing path instead.
- A nonsense-path control on the host returned a 404 at a distinct size against a 200 for real pages, so this host discriminates on both status and size.
- The FDA warning-letter screen ran on the company's own domain and published address, with a known-positive and a known-negative control passing in the same run. One candidate letter came back and was re-checked against the company's own domain and address; it is a different entity.
The page we read — all on
- Signup page
Personalized Care: GLP-1 Injection Starting at $199/mo
This link pays us nothing. It's here because the price is checkable.
Alternatives to VivioMD
| Provider | Grade | Cheapest price |
|---|---|---|
| Fridays | CCaveat | $117/mo |
| Andrew Meds | BMinor gap | $199/mo |
| Ascend Vitality | CCaveat | $199/mo |
| BloomWell Rx | CCaveat | $199/mo |
| Calibrate Health | CCaveat | $199/mo |